The whey protein osteopontin has been identified in human milk, whereas only small quantities are present in bovine milk. As a consequence infant formulas have a significantly lower content of osteopontin than human breast milk which may impact areas like immune development.
Osteopontin is a heavily phosphorylated, acidic glycoprotein with strong calcium-binding properties. At Arla Foods Ingredients we can provide you with min. 95% pure form of osteopontin, Lacprodan® OPN-10, which was the first osteopontin product on the market.
The research in osteopotin
Preliminary research suggests that osteopontin plays a part in the development of infant immune functions, promoting maturation of the immune system and protecting against pathogenic infections. The addition of Lacprodan® OPN-10 to an infant formula may encourage similar immune modulation in formula-fed infants compared to breastfed infants. It therefore could be the missing link in infant formulas to deliver immune protection similar to human milk.
Benefits associated with osteopontin:
At Arla Foods Ingredients, we hold several patents for production and application of osteopontin.
Osteopontin - product range:
- Lacprodan® OPN-10: osteopontin fractionated from bovine milk. Osteopontin content of protein is min 95%
Osteopontin - awards:
- Lacprodan® OPN-10: Winner of 2017 NutraIngredients Awards for “Ingredient of the Year – Immunity”
- Lacprodan® OPN-10: Winner of 2018 Frost & Sullivan Best Practices Award for “Global Infant Nutrition Product Leadership”.
Lönnerdal et al. 2016. J Pediatr Gastroenterol Nutr. 62: 650-657
Christensen & Sørensen 2016. Int Dairy J. 57: 1-6
Arla Foods Ingredients supports the WHO recommendation for exclusive breastfeeding for the first six months of an infant’s life and continued breastfeeding up to the age of two or beyond in combination with nutritionally appropriate complementary foods.